Description

Azilect (Rasagiline) tablets 1 mg. №30

Ingredients:

Each tablet contains 1 mg of Rasagiline.

Dosage:

The recommended dosage is 1 mg once daily. It can be taken with or without food.

Indications:

Azilect (Rasagiline) is indicated for the treatment of Parkinson’s disease. It helps improve the symptoms of the disease and may slow down its progression.

Contraindications:

Do not use Azilect if you are taking meperidine or have severe liver disease. Consult your doctor before starting this medication.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow your doctor’s instructions carefully.

Scientific Evidence:

Rasagiline, the active ingredient in Azilect, is a selective irreversible MAO-B inhibitor. It works by increasing dopamine levels in the brain, which helps improve motor symptoms in Parkinson’s disease. Studies have shown that Rasagiline is effective in reducing motor fluctuations and dyskinesia in patients with Parkinson’s disease.

Additional Information:

Azilect has been well-studied in clinical trials and has been shown to be effective in the treatment of Parkinson’s disease. It is generally well-tolerated, with common side effects including headache, joint pain, and indigestion. It is important to follow your doctor’s recommendations and report any unusual symptoms while taking Azilect.

Research published in the Journal of Neural Transmission demonstrated the efficacy of Rasagiline in improving motor function and reducing disability in patients with Parkinson’s disease. The study highlighted the long-term benefits of Rasagiline therapy in managing the symptoms of the disease.